Table 3 Uni- and multivariate analyses for BMQ necessity-concern differential

Gender

0.933 [-1.551–3,416]

0.460

Age

0.120 [0.041–0.199]

0.003

0.048 [-0.038–0.135]

0.269

Low level of education

-1.299 [-2.201 – -0.396]

0.005

-1.092 [-2.068 – -0.117]

0.028

Comorbidity

0.035 [-1.345–1.415]

0.960

Disease duration in years

0.020 [0.094–0.135]

0.725

VAS pain

0.123 [-0.266–0.512]

0.535

Disease activity

0.991 [0.113–1.869]

0.027

0.537 [-0.385–1.459]

0.251

Corticotherapy use

2.024 [-0.061–4.110]

0.057

Methotrexate use

3.283 [1.185–5.381]

0.002

2.604 [0.314–4.893]

0.026

Biologic therapy use

3.534 [-0.888–7.956]

0.117

PCS

-2.650 [-4.833 – -0.467]

0.018

-2.461 [-4.713 – -0.210]

0.032

TPS

0.288 [0.138–0.439]

< 0.001

0.198 [-0.040–0.357]

0.014